1614 related articles for article (PubMed ID: 19183224)
1. Impact of nonadherence to antiepileptic drugs on health care utilization and costs: findings from the RANSOM study.
Faught RE; Weiner JR; Guérin A; Cunnington MC; Duh MS
Epilepsia; 2009 Mar; 50(3):501-9. PubMed ID: 19183224
[TBL] [Abstract][Full Text] [Related]
2. Nonadherence to antiepileptic drugs and increased mortality: findings from the RANSOM Study.
Faught E; Duh MS; Weiner JR; Guérin A; Cunnington MC
Neurology; 2008 Nov; 71(20):1572-8. PubMed ID: 18565827
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and cost of nonadherence with antiepileptic drugs in an adult managed care population.
Davis KL; Candrilli SD; Edin HM
Epilepsia; 2008 Mar; 49(3):446-54. PubMed ID: 18031549
[TBL] [Abstract][Full Text] [Related]
4. Burden of chronic obstructive pulmonary disease in Medicare beneficiaries residing in long-term care facilities.
Simoni-Wastila L; Blanchette CM; Qian J; Yang HW; Zhao L; Zuckerman IH; Pak GH; Silver H; Dalal AA
Am J Geriatr Pharmacother; 2009 Oct; 7(5):262-70. PubMed ID: 19948302
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and cost of nonadherence to antiepileptic drugs in elderly patients with epilepsy.
Ettinger AB; Manjunath R; Candrilli SD; Davis KL
Epilepsy Behav; 2009 Feb; 14(2):324-9. PubMed ID: 19028602
[TBL] [Abstract][Full Text] [Related]
6. Burden of uncontrolled epilepsy in patients requiring an emergency room visit or hospitalization.
Manjunath R; Paradis PE; Parisé H; Lafeuille MH; Bowers B; Duh MS; Lefebvre P; Faught E
Neurology; 2012 Oct; 79(18):1908-16. PubMed ID: 23077014
[TBL] [Abstract][Full Text] [Related]
7. Economic impact of epilepsy and the cost of nonadherence to antiepileptic drugs in older Medicare beneficiaries.
Ip Q; Malone DC; Chong J; Harris RB; Labiner DM
Epilepsy Behav; 2018 Mar; 80():208-214. PubMed ID: 29414554
[TBL] [Abstract][Full Text] [Related]
8. Utilization and costs for children who have special health care needs and are enrolled in a hospital-based comprehensive primary care clinic.
Berman S; Rannie M; Moore L; Elias E; Dryer LJ; Jones MD
Pediatrics; 2005 Jun; 115(6):e637-42. PubMed ID: 15930189
[TBL] [Abstract][Full Text] [Related]
9. Medicaid beneficiaries with congestive heart failure: association of medication adherence with healthcare use and costs.
Esposito D; Bagchi AD; Verdier JM; Bencio DS; Kim MS
Am J Manag Care; 2009 Jul; 15(7):437-45. PubMed ID: 19589011
[TBL] [Abstract][Full Text] [Related]
10. Medical utilization and costs associated with statin adherence in Medicaid enrollees with type 2 diabetes.
Wu J; Seiber E; Lacombe VA; Nahata MC; Balkrishnan R
Ann Pharmacother; 2011 Mar; 45(3):342-9. PubMed ID: 21325098
[TBL] [Abstract][Full Text] [Related]
11. Case-control analysis of ambulance, emergency room, or inpatient hospital events for epilepsy and antiepileptic drug formulation changes.
Zachry WM; Doan QD; Clewell JD; Smith BJ
Epilepsia; 2009 Mar; 50(3):493-500. PubMed ID: 18616554
[TBL] [Abstract][Full Text] [Related]
12. Treatment failure rates and health care utilization and costs among patients with community-acquired pneumonia treated with levofloxacin or macrolides in an outpatient setting: a retrospective claims database analysis.
Ye X; Sikirica V; Schein JR; Grant R; Zarotsky V; Doshi D; Benson CJ; Riedel AA
Clin Ther; 2008 Feb; 30(2):358-71. PubMed ID: 18343274
[TBL] [Abstract][Full Text] [Related]
13. Analysis of costs, length of stay, and utilization of emergency department services by frequent users: implications for health policy.
Ruger JP; Richter CJ; Spitznagel EL; Lewis LM
Acad Emerg Med; 2004 Dec; 11(12):1311-7. PubMed ID: 15576522
[TBL] [Abstract][Full Text] [Related]
14. Comparison of hospitalizations, emergency department visits, and costs in a historical cohort of Texas Medicaid patients with chronic obstructive pulmonary disease, by initial medication regimen.
Rascati KL; Akazawa M; Johnsrud M; Stanford RH; Blanchette CM
Clin Ther; 2007 Jun; 29(6):1203-13. PubMed ID: 17692734
[TBL] [Abstract][Full Text] [Related]
15. Risk of hospitalizations/emergency department visits and treatment costs associated with initial maintenance therapy using fluticasone propionate 500 microg/salmeterol 50 microg compared with ipratropium for chronic obstructive pulmonary disease in older adults.
Blanchette CM; Akazawa M; Dalal A; Simoni-Wastila L
Am J Geriatr Pharmacother; 2008 Aug; 6(3):138-46. PubMed ID: 18775388
[TBL] [Abstract][Full Text] [Related]
16. Outpatient antipsychotic treatment and inpatient costs of schizophrenia.
Marcus SC; Olfson M
Schizophr Bull; 2008 Jan; 34(1):173-80. PubMed ID: 17578893
[TBL] [Abstract][Full Text] [Related]
17. Asthma prevalence, cost, and adherence with expert guidelines on the utilization of health care services and costs in a state Medicaid population.
Piecoro LT; Potoski M; Talbert JC; Doherty DE
Health Serv Res; 2001 Jun; 36(2):357-71. PubMed ID: 11409817
[TBL] [Abstract][Full Text] [Related]
18. Review and analysis of hospitalization costs associated with antipsychotic nonadherence in the treatment of schizophrenia in the United States.
Sun SX; Liu GG; Christensen DB; Fu AZ
Curr Med Res Opin; 2007 Oct; 23(10):2305-12. PubMed ID: 17697454
[TBL] [Abstract][Full Text] [Related]
19. Medication adherence and the associated health-economic impact among patients with type 2 diabetes mellitus converting to insulin pen therapy: an analysis of third-party managed care claims data.
Lee WC; Balu S; Cobden D; Joshi AV; Pashos CL
Clin Ther; 2006 Oct; 28(10):1712-25; discussion 1710-1. PubMed ID: 17157128
[TBL] [Abstract][Full Text] [Related]
20. Comparisons of rosiglitazone versus pioglitazone monotherapy introduction and associated health care utilization in Medicaid-enrolled patients with type 2 diabetes mellitus.
Balkrishnan R; Arondekar BV; Camacho FT; Shenolikar RA; Horblyuk R; Anderson RT
Clin Ther; 2007 Jun; 29(6 Pt 1):1306-15. PubMed ID: 18036392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
